{"entity":{"type":"insider","cik":"0001287235","url":"/insider/0001287235","json_url":"/insider/0001287235.json","name":"TIDMARSH GEORGE F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":24,"first":"2005-03-15","last":"2023-12-12","span_basis":"filed_date"},"name_variants":[{"name":"TIDMARSH GEORGE F","source":"filing","n_filings":24,"first_seen":"2005-03-15","last_seen":"2023-12-12"}],"transactions":[{"id":8000217,"accession":"0001209191-23-058296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058296","line_url":"/filing/0001209191-23-058296#line-1","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27771.0,"shares_display":"27,771","price_per_share":0.5199,"price_display":"0.52","price_state":"stated","total_value":14438.1429,"total_display":"14,438.14","total_whole":"14,438","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-08","filed_date":"2023-12-12","scope":"insider"},{"id":8753646,"accession":"0001209191-23-052953","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052953","line_url":"/filing/0001209191-23-052953#line-1","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10957.0,"shares_display":"10,957","price_per_share":0.661,"price_display":"0.66","price_state":"stated","total_value":7242.577,"total_display":"7,242.58","total_whole":"7,243","shares_owned_after":42096.0,"shares_owned_after_display":"42,096","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-17","scope":"insider"},{"id":7836726,"accession":"0001209191-23-053102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-053102","line_url":"/filing/0001209191-23-053102#line-1","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1845.0,"shares_display":"1,845","price_per_share":0.6501,"price_display":"0.65","price_state":"stated","total_value":1199.4345,"total_display":"1,199.43","total_whole":"1,199","shares_owned_after":27771.0,"shares_owned_after_display":"27,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-18","scope":"insider"},{"id":7816545,"accession":"0001209191-23-051037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-051037","line_url":"/filing/0001209191-23-051037#line-1","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1429.0,"shares_display":"1,429","price_per_share":0.69,"price_display":"0.69","price_state":"stated","total_value":986.01,"total_display":"986.01","total_whole":"986","shares_owned_after":42096.0,"shares_owned_after_display":"42,096","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-10-02","scope":"insider"},{"id":8116758,"accession":"0001209191-23-049786","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-049786","line_url":"/filing/0001209191-23-049786#line-3","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":0.74,"price_display":"0.74","price_state":"stated","total_value":2960.0,"total_display":"2,960.00","total_whole":"2,960","shares_owned_after":39348.0,"shares_owned_after_display":"39,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-18","scope":"insider"},{"id":8116753,"accession":"0001209191-23-049786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-049786","line_url":"/filing/0001209191-23-049786#line-2","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":0.73,"price_display":"0.73","price_state":"stated","total_value":6935.0,"total_display":"6,935.00","total_whole":"6,935","shares_owned_after":43348.0,"shares_owned_after_display":"43,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-18","scope":"insider"},{"id":8116750,"accession":"0001209191-23-049786","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049786","line_url":"/filing/0001209191-23-049786#line-1","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":52848.0,"shares_owned_after_display":"52,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-14","filed_date":"2023-09-18","scope":"insider"},{"id":8042331,"accession":"0001209191-23-024898","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-024898","line_url":"/filing/0001209191-23-024898#line-2","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":29000.0,"total_display":"29,000.00","total_whole":"29,000","shares_owned_after":64848.0,"shares_owned_after_display":"64,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-19","scope":"insider"},{"id":8042328,"accession":"0001209191-23-024898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-024898","line_url":"/filing/0001209191-23-024898#line-1","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26500.0,"shares_display":"26,500","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":30740.0,"total_display":"30,740.00","total_whole":"30,740","shares_owned_after":39848.0,"shares_owned_after_display":"39,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-19","scope":"insider"},{"id":6668330,"accession":"0001209191-22-013741","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-013741","line_url":"/filing/0001209191-22-013741#line-1","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":32000.0,"total_display":"32,000.00","total_whole":"32,000","shares_owned_after":467156.0,"shares_owned_after_display":"467,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-25","filed_date":"2022-02-28","scope":"insider"},{"id":6242753,"accession":"0001209191-22-008580","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008580","line_url":"/filing/0001209191-22-008580#line-2","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":2.5533,"price_display":"2.55","price_state":"stated","total_value":76599.0,"total_display":"76,599.00","total_whole":"76,599","shares_owned_after":447156.0,"shares_owned_after_display":"447,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-10","scope":"insider"},{"id":6242748,"accession":"0001209191-22-008580","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-008580","line_url":"/filing/0001209191-22-008580#line-1","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.54,"price_display":"2.54","price_state":"stated","total_value":2540.0,"total_display":"2,540.00","total_whole":"2,540","shares_owned_after":417156.0,"shares_owned_after_display":"417,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-10","scope":"insider"},{"id":9271664,"accession":"0001209191-22-008025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008025","line_url":"/filing/0001209191-22-008025#line-2","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42100.0,"shares_display":"42,100","price_per_share":2.6076,"price_display":"2.61","price_state":"stated","total_value":109779.96,"total_display":"109,779.96","total_whole":"109,780","shares_owned_after":1523335.0,"shares_owned_after_display":"1,523,335","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider"},{"id":6242694,"accession":"0001209191-22-007837","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-007837","line_url":"/filing/0001209191-22-007837#line-2","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42100.0,"shares_display":"42,100","price_per_share":2.6076,"price_display":"2.61","price_state":"stated","total_value":109779.96,"total_display":"109,779.96","total_whole":"109,780","shares_owned_after":1523335.0,"shares_owned_after_display":"1,523,335","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-08","scope":"insider"},{"id":9271666,"accession":"0001209191-22-008025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-008025","line_url":"/filing/0001209191-22-008025","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9900.0,"shares_display":"9,900","price_per_share":2.33900101010101,"price_display":"2.34","price_state":"stated","total_value":23156.11,"total_display":"23,156.11","total_whole":"23,156","shares_owned_after":1481235.0,"shares_owned_after_display":"1,481,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-04","filed_date":"2022-02-09","scope":"insider","n_lines":2},{"id":6242690,"accession":"0001209191-22-007837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-007837","line_url":"/filing/0001209191-22-007837#line-1","is_derivative":false,"issuer_cik":"0001287235","issuer_name":"REVELATION BIOSCIENCES, INC.","issuer_ticker":"REVB","issuer_name_source":null,"issuer_url":"/issuer/0001287235","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7900.0,"shares_display":"7,900","price_per_share":2.3109,"price_display":"2.31","price_state":"stated","total_value":18256.11,"total_display":"18,256.11","total_whole":"18,256","shares_owned_after":1481235.0,"shares_owned_after_display":"1,481,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-04","filed_date":"2022-02-08","scope":"insider"},{"id":7910714,"accession":"0000920465-19-000011","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000920465-19-000011","line_url":"/filing/0000920465-19-000011","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.85,"price_display":"5.85","price_state":"stated","total_value":11700.0,"total_display":"11,700.00","total_whole":"11,700","shares_owned_after":1282890.0,"shares_owned_after_display":"1,282,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-09","scope":"insider","n_lines":6},{"id":4928378,"accession":"0000920465-17-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000920465-17-000037","line_url":"/filing/0000920465-17-000037#line-2","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":34.15,"price_display":"34.15","price_state":"stated","total_value":34150.0,"total_display":"34,150.00","total_whole":"34,150","shares_owned_after":1354086.0,"shares_owned_after_display":"1,354,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-03","filed_date":"2017-03-06","scope":"insider"},{"id":4928373,"accession":"0000920465-17-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000920465-17-000037","line_url":"/filing/0000920465-17-000037#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":34.1773,"price_display":"34.18","price_state":"stated","total_value":68354.6,"total_display":"68,354.60","total_whole":"68,355","shares_owned_after":1353086.0,"shares_owned_after_display":"1,353,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-02","filed_date":"2017-03-06","scope":"insider"},{"id":2311715,"accession":"0000920465-16-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000920465-16-000109","line_url":"/filing/0000920465-16-000109","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":16.57,"price_display":"16.57","price_state":"stated","total_value":33140.0,"total_display":"33,140.00","total_whole":"33,140","shares_owned_after":1425086.0,"shares_owned_after_display":"1,425,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-03","scope":"insider","n_lines":2},{"id":8807472,"accession":"0000920465-15-000042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000920465-15-000042","line_url":"/filing/0000920465-15-000042","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":18.37,"price_display":"18.37","price_state":"stated","total_value":73480.0,"total_display":"73,480.00","total_whole":"73,480","shares_owned_after":22000.0,"shares_owned_after_display":"22,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2015-05-13","scope":"insider","n_lines":2},{"id":6393393,"accession":"0000920465-14-000129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000920465-14-000129","line_url":"/filing/0000920465-14-000129#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":11.38,"price_display":"11.38","price_state":"stated","total_value":45520.0,"total_display":"45,520.00","total_whole":"45,520","shares_owned_after":1421086.0,"shares_owned_after_display":"1,421,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-12","scope":"insider"},{"id":6248297,"accession":"0000920465-14-000106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000920465-14-000106","line_url":"/filing/0000920465-14-000106#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":9.35,"price_display":"9.35","price_state":"stated","total_value":18700.0,"total_display":"18,700.00","total_whole":"18,700","shares_owned_after":1417086.0,"shares_owned_after_display":"1,417,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-26","filed_date":"2014-09-30","scope":"insider"},{"id":6393390,"accession":"0000920465-14-000104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000920465-14-000104","line_url":"/filing/0000920465-14-000104#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":9.18,"price_display":"9.18","price_state":"stated","total_value":45900.0,"total_display":"45,900.00","total_whole":"45,900","shares_owned_after":1415086.0,"shares_owned_after_display":"1,415,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-18","filed_date":"2014-09-22","scope":"insider"},{"id":7025233,"accession":"0000920465-14-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000920465-14-000082","line_url":"/filing/0000920465-14-000082#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19000.0,"shares_display":"19,000","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":199500.0,"total_display":"199,500.00","total_whole":"199,500","shares_owned_after":1410086.0,"shares_owned_after_display":"1,410,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-23","filed_date":"2014-07-25","scope":"insider"},{"id":7093494,"accession":"0001209191-14-036356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-036356","line_url":"/filing/0001209191-14-036356#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":7.37,"price_display":"7.37","price_state":"stated","total_value":88440.0,"total_display":"88,440.00","total_whole":"88,440","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-21","filed_date":"2014-05-22","scope":"insider"},{"id":6424672,"accession":"0000904454-14-000377","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000904454-14-000377","line_url":"/filing/0000904454-14-000377","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":9.3,"price_display":"9.30","price_state":"stated","total_value":37200.0,"total_display":"37,200.00","total_whole":"37,200","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-14","filed_date":"2014-04-14","scope":"insider","n_lines":2},{"id":6424666,"accession":"0000904454-14-000377","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-14-000377","line_url":"/filing/0000904454-14-000377","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":9.76,"price_display":"9.76","price_state":"stated","total_value":39040.0,"total_display":"39,040.00","total_whole":"39,040","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-11","filed_date":"2014-04-14","scope":"insider","n_lines":2},{"id":6275293,"accession":"0000904454-14-000162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-14-000162","line_url":"/filing/0000904454-14-000162#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (President, CEO & Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":7.25,"price_display":"7.25","price_state":"stated","total_value":21750.0,"total_display":"21,750.00","total_whole":"21,750","shares_owned_after":1391086.0,"shares_owned_after_display":"1,391,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-07","filed_date":"2014-02-11","scope":"insider"},{"id":7260114,"accession":"0001209191-10-042658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-042658","line_url":"/filing/0001209191-10-042658#line-1","is_derivative":false,"issuer_cik":"0000831547","issuer_name":"SPECTRUM PHARMACEUTICALS INC","issuer_ticker":"SPPI","issuer_name_source":null,"issuer_url":"/issuer/0000831547","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Officer (CSO AND HEAD OF R&D OPERATIONS)","role_mark":"O","role_mark_label":"Officer (CSO AND HEAD OF R&D OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO AND HEAD OF R&D OPERATIONS","security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.03,"price_display":"4.03","price_state":"stated","total_value":20150.0,"total_display":"20,150.00","total_whole":"20,150","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-13","filed_date":"2010-08-16","scope":"insider"},{"id":9073082,"accession":"0001209191-11-009304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-009304","line_url":"/filing/0001209191-11-009304#line-1","is_derivative":false,"issuer_cik":"0000831547","issuer_name":"SPECTRUM PHARMACEUTICALS INC","issuer_ticker":"SPPI","issuer_name_source":null,"issuer_url":"/issuer/0000831547","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Officer (CSO and Head of R&D Operations)","role_mark":"O","role_mark_label":"Officer (CSO and Head of R&D Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO and Head of R&D Operations","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1125.0,"shares_display":"1,125","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":4398.75,"total_display":"4,398.75","total_whole":"4,399","shares_owned_after":22818.0,"shares_owned_after_display":"22,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-23","filed_date":"2011-02-14","scope":"insider"},{"id":1351381,"accession":"0001181431-05-016948","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001181431-05-016948","line_url":"/filing/0001181431-05-016948","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (Founder and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Founder and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.8971503,"price_display":"5.90","price_state":"stated","total_value":5897.1503,"total_display":"5,897.15","total_whole":"5,897","shares_owned_after":991760.0,"shares_owned_after_display":"991,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-11","filed_date":"2005-03-15","scope":"insider","n_lines":3},{"id":1351378,"accession":"0001181431-05-016948","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-05-016948","line_url":"/filing/0001181431-05-016948#line-7","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (Founder and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Founder and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":5.977,"price_display":"5.98","price_state":"stated","total_value":5379.3,"total_display":"5,379.30","total_whole":"5,379","shares_owned_after":991219.0,"shares_owned_after_display":"991,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-10","filed_date":"2005-03-15","scope":"insider"},{"id":1351377,"accession":"0001181431-05-016948","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-05-016948","line_url":"/filing/0001181431-05-016948#line-6","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (Founder and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Founder and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":5.974,"price_display":"5.97","price_state":"stated","total_value":5376.6,"total_display":"5,376.60","total_whole":"5,377","shares_owned_after":990319.0,"shares_owned_after_display":"990,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-10","filed_date":"2005-03-15","scope":"insider"},{"id":1351376,"accession":"0001181431-05-016948","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-05-016948","line_url":"/filing/0001181431-05-016948#line-5","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (Founder and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Founder and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":5.94,"price_display":"5.94","price_state":"stated","total_value":4158.0,"total_display":"4,158.00","total_whole":"4,158","shares_owned_after":989419.0,"shares_owned_after_display":"989,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-10","filed_date":"2005-03-15","scope":"insider"},{"id":1351375,"accession":"0001181431-05-016948","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-05-016948","line_url":"/filing/0001181431-05-016948#line-4","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (Founder and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Founder and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":5.93,"price_display":"5.93","price_state":"stated","total_value":1186.0,"total_display":"1,186.00","total_whole":"1,186","shares_owned_after":988719.0,"shares_owned_after_display":"988,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-10","filed_date":"2005-03-15","scope":"insider"},{"id":1351374,"accession":"0001181431-05-016948","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-05-016948","line_url":"/filing/0001181431-05-016948#line-3","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (Founder and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Founder and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.99,"price_display":"5.99","price_state":"stated","total_value":599.0,"total_display":"599.00","total_whole":"599","shares_owned_after":988419.0,"shares_owned_after_display":"988,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-10","filed_date":"2005-03-15","scope":"insider"},{"id":1351373,"accession":"0001181431-05-016948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-016948","line_url":"/filing/0001181431-05-016948#line-2","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":"0001287235","owner_name":"TIDMARSH GEORGE F","owner_display_name":"TIDMARSH GEORGE F","owner_url":"/insider/0001287235","role":"Director, Officer (Founder and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Founder and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.99,"price_display":"5.99","price_state":"stated","total_value":599.0,"total_display":"599.00","total_whole":"599","shares_owned_after":988319.0,"shares_owned_after_display":"988,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-10","filed_date":"2005-03-15","scope":"insider"}],"collapsed":true,"next_cursor":"2005-03-10|1351373","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":44,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001810560","name":"REVELATION BIOSCIENCES, INC.","url":"/issuer/0001810560","role":"Director, Ten percent owner","n_filings":10,"first_seen":"2022-02-08","last_seen":"2023-12-12"},{"type":"issuer","type_label":"ISSUER","cik":"0000920465","name":"LA JOLLA PHARMACEUTICAL CO","url":"/issuer/0000920465","role":"Director, Officer (President, CEO & Secretary), Ten percent owner","n_filings":11,"first_seen":"2014-02-11","last_seen":"2019-01-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000831547","name":"SPECTRUM PHARMACEUTICALS INC","url":"/issuer/0000831547","role":"Officer (CSO and Head of R&D Operations)","n_filings":2,"first_seen":"2010-08-16","last_seen":"2011-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001183765","name":"THRESHOLD PHARMACEUTICALS INC","url":"/issuer/0001183765","role":"Director, Officer (Founder and President)","n_filings":1,"first_seen":"2005-03-15","last_seen":"2005-03-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001287235","retrieved_at":"2026-08-27T12:37:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}